المؤلفون: Broman, Kristy K., Hughes, Tasha M., Bredbeck, Brooke C., Sun, James, Kirichenko, Dennis, Carr, Michael J., Sharma, Avinash, Bartlett, Edmund K., Nijhuis, Amanda A.G., Thompson, John F., Hieken, Tina J., Kottschade, Lisa, Downs, Jennifer, Gyorki, David E., Stahlie, Emma, Van Akkooi, Alexander, Ollila, David W., O’shea, Kristin, Song, Yun, Karakousis, Giorgos, Moncrieff, Marc, Nobes, Jenny, Vetto, John, Han, Dale, Hotz, Meghan, Farma, Jeffrey M., Deneve, Jeremiah L., Fleming, Martin D., Perez, Matthew, Baecher, Kirsten, Lowe, Michael, Bagge, Roger Olofsson, Mattsson, Jan, Lee, Ann Y., Berman, Russell S., Chai, Harvey, Kroon, Hidde M., Teras, Juri, Teras, Roland M., Farrow, Norma E., Beasley, Georgia M., Hui, Jane Yuet Ching, Been, Lukas, Kruijff, Schelto, Sinco, Brandy, Sarnaik, Amod A., Sondak, Vernon K., Zager, Jonathan S., Dossett, Lesly A.

المصدر: Broman , K K , Hughes , T M , Bredbeck , B C , Sun , J , Kirichenko , D , Carr , M J , Sharma , A , Bartlett , E K , Nijhuis , A A G , Thompson , J F , Hieken , T J , Kottschade , L , Downs , J , Gyorki , D E , Stahlie , E , Van Akkooi , A , Ollila , D W , O’shea , K , Song , Y , Karakousis , G , Moncrieff , M , Nobes , J ....

مصطلحات موضوعية: active surveillance, adjuvant therapy, completion lymph node dissection, de-implementation, implementation science, melanoma, sentinel lymph node

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/6b3618cb-0074-40b6-8a91-f80ad0d3c8ddTest

الإتاحة: https://doi.org/10.1097/SLA.0000000000005370Test
https://hdl.handle.net/11370/6b3618cb-0074-40b6-8a91-f80ad0d3c8ddTest
https://research.rug.nl/en/publications/6b3618cb-0074-40b6-8a91-f80ad0d3c8ddTest
https://pure.rug.nl/ws/files/669190680/International_Center_Level_Variation_in.39.pdfTest

المؤلفون: Broman, Kristy Kummerow, Hughes, Tasha, Dossett, Lesly, Sun, James, Kirichenko, Dennis, Carr, Michael J., Sharma, Avinash, Bartlett, Edmund K., Nijhuis, Amanda A. G., Thompson, John F., Hieken, Tina J., Kottschade, Lisa, Downs, Jennifer, Gyorki, David E., Stahlie, Emma, van Akkooi, Alexander, Ollila, David W., Frank, Jill, Song, Yun, Karakousis, Giorgos, Moncrieff, Marc, Nobes, Jenny, Vetto, John, Han, Dale, Farma, Jeffrey M., Deneve, Jeremiah L., Fleming, Martin D., Perez, Matthew C., Lowe, Michael C., Olofsson Bagge, Roger, Mattsson, Jan, Lee, Ann Y., Berman, Russell S., Chai, Harvey, Kroon, Hidde M., Teras, Juri, Teras, Roland M., Farrow, Norma E., Beasley, Georgia, Hui, Jane Yuet Ching, Been, Lukas, Kruijff, Schelto, Kim, Youngchul, Naqvi, Syeda Mahrukh Hussnain, Sarnaik, Amod A., Sondak, Vernon K., Zager, Jonathan S.

المصدر: Broman , K K , Hughes , T , Dossett , L , Sun , J , Kirichenko , D , Carr , M J , Sharma , A , Bartlett , E K , Nijhuis , A A G , Thompson , J F , Hieken , T J , Kottschade , L , Downs , J , Gyorki , D E , Stahlie , E , van Akkooi , A , Ollila , D W , Frank , J , Song , Y , Karakousis , G , Moncrieff , M , Nobes , J , Vetto ....

مصطلحات موضوعية: active surveillance, cohort studies, cutaneous malignant melanoma, follow‐, up studies, immunotherapy, lymph node excision, metastatic melanoma, sentinel lymph node

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/1345b378-7be2-4007-8be7-6a109259b8a8Test

الإتاحة: https://doi.org/10.1002/cncr.33483Test
https://hdl.handle.net/11370/1345b378-7be2-4007-8be7-6a109259b8a8Test
https://research.rug.nl/en/publications/1345b378-7be2-4007-8be7-6a109259b8a8Test
https://pure.rug.nl/ws/files/178374520/cncr.33483.pdfTest

المؤلفون: Broman, Kristy Kummerow, Hughes, Tasha, Dossett, Lesly, Sun, James, Kirichenko, Dennis, Carr, Michael J., Sharma, Avinash, Bartlett, Edmund K., Nijhuis, Amanda A. G., Thompson, John F., Hieken, Tina J., Kottschade, Lisa, Downs, Jennifer, Gyorki, David E., Stahlie, Emma, Akkooi, Alexander, Ollila, David W., Frank, Jill, Song, Yun, Karakousis, Giorgos, Moncrieff, Marc, Nobes, Jenny, Vetto, John, Han, Dale, Farma, Jeffrey M., Deneve, Jeremiah L., Fleming, Martin D., Perez, Matthew C., Lowe, Michael C., Olofsson Bagge, Roger, Mattsson, Jan, Lee, Ann Y., Berman, Russell S., Chai, Harvey, Kroon, Hidde M., Teras, Juri, Teras, Roland M., Farrow, Norma E., Beasley, Georgia, Hui, Jane Yuet Ching, Been, Lukas, Kruijff, Schelto, Kim, Youngchul, Naqvi, Syeda Mahrukh Hussnain, Sarnaik, Amod A., Sondak, Vernon K., Zager, Jonathan S.

مصطلحات موضوعية: sentinel lymph node, active surveillance, cohort studies, cutaneous malignant melanoma, follow‐up studies, immunotherapy, lymph node excision, metastatic melanoma, Oncology and Hematology, Public Health, Health Sciences

وصف الملف: application/pdf

العلاقة: Broman, Kristy Kummerow; Hughes, Tasha; Dossett, Lesly; Sun, James; Kirichenko, Dennis; Carr, Michael J.; Sharma, Avinash; Bartlett, Edmund K.; Nijhuis, Amanda A. G.; Thompson, John F.; Hieken, Tina J.; Kottschade, Lisa; Downs, Jennifer; Gyorki, David E.; Stahlie, Emma; Akkooi, Alexander; Ollila, David W.; Frank, Jill; Song, Yun; Karakousis, Giorgos; Moncrieff, Marc; Nobes, Jenny; Vetto, John; Han, Dale; Farma, Jeffrey M.; Deneve, Jeremiah L.; Fleming, Martin D.; Perez, Matthew C.; Lowe, Michael C.; Olofsson Bagge, Roger; Mattsson, Jan; Lee, Ann Y.; Berman, Russell S.; Chai, Harvey; Kroon, Hidde M.; Teras, Juri; Teras, Roland M.; Farrow, Norma E.; Beasley, Georgia; Hui, Jane Yuet Ching; Been, Lukas; Kruijff, Schelto; Kim, Youngchul; Naqvi, Syeda Mahrukh Hussnain; Sarnaik, Amod A.; Sondak, Vernon K.; Zager, Jonathan S. (2021). "Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2)." Cancer (13): 2251-2261.; https://hdl.handle.net/2027.42/168248Test; Cancer; Eggermont AMM, Blank CU, Mandala M, et al. Adjuvant pembrolizumab versus placebo in resected stage III melanoma. N Engl J Med. 2018; 378: 1789 ‐ 1801.; Eggermont AM, Chiarion‐Sileni V, Grob JJ, et al. Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy. N Engl J Med. 2016; 375: 1845 ‐ 1855.; Eggermont AM, Chiarion‐Sileni V, Grob JJ, et al. Adjuvant ipilimumab versus placebo after complete resection of high‐risk stage III melanoma (EORTC 18071): a randomised, double‐blind, phase 3 trial. Lancet Oncol. 2015; 16: 522 ‐ 530.; Leiter U, Stadler R, Mauch C, et al. Final analysis of DeCOG‐SLT trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node. J Clin Oncol. 2019; 37: 3000 ‐ 3008.; Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG‐SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016; 17: 757 ‐ 767.; Leiter U, Buettner PG, Eigentler TK, Forschner A, Meier F, Garbe C. Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit? Melanoma Res. 2010; 20: 240 ‐ 246.; Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel‐node metastasis in melanoma. N Engl J Med. 2017; 376: 2211 ‐ 2222.; Klemen ND, Han G, Leong SP, et al. Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefit. J Surg Oncol. 2019; 119: 1053 ‐ 1059.; Wong SL, Morton DL, Thompson JF, et al. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi‐institutional study. Ann Surg Oncol. 2006; 13: 809 ‐ 816.; Kwak M, Farrow NE, Salama AKS, et al. Updates in adjuvant systemic therapy for melanoma. J Surg Oncol. 2019; 119: 222 ‐ 231.; Coit D. The enigma of regional lymph nodes in melanoma. N Engl J Med. 2017; 376: 2280 ‐ 2281.; McMasters KM, Wong SL, Edwards MJ, et al. Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol. 2002; 9: 137 ‐ 141.; Herb JN, Dunham LN, Ollila DW, Stitzenberg KB, Meyers MO. Use of completion lymph node dissection for sentinel lymph node‐positive melanoma. J Am Coll Surg. 2020; 230: 515 ‐ 524.; Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999; 94: 496 ‐ 509.; Gray RJ. A class of K‐sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988; 16: 1141 ‐ 1154.; Lin DY. MULCOX2: a general computer program for the Cox regression analysis of multivariate failure time data. Comput Methods Programs Biomed. 1993; 40: 279 ‐ 293.; Long GV, Hauschild A, Santinami M, et al. Adjuvant dabrafenib plus trametinib in stage III BRAF‐mutated melanoma. N Engl J Med. 2017; 377: 1813 ‐ 1823.; Weber J, Mandala M, Del Vecchio M, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med. 2017; 377: 1824 ‐ 1835.; Verver D, van Klaveren D, van Akkooi ACJ, et al. Risk stratification of sentinel node‐positive melanoma patients defines surgical management and adjuvant therapy treatment considerations. Eur J Cancer. 2018; 96: 25 ‐ 33.; Leon‐Ferre RA, Kottschade LA, Block MS, et al. Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high‐risk melanoma. Melanoma Res. 2017; 27: 335 ‐ 341.; Freeman M, Laks S. Surveillance imaging for metastasis in high‐risk melanoma: importance in individualized patient care and survivorship. Melanoma Manag. 2019; 6: MMT12.; Dinnes J, Ferrante di Ruffano L, Takwoingi Y, et al. Ultrasound, CT, MRI, or PET‐CT for staging and re‐staging of adults with cutaneous melanoma. Cochrane Database Syst Rev. 2019; 7: CD012806.; Xing Y, Bronstein Y, Ross MI, et al. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta‐analysis. J Natl Cancer Inst. 2011; 103: 129 ‐ 142.; Eroglu Z, Babacan N, Grossman K, et al. Retrospective analysis of patients with sentinel lymph node (SNL) positive melanoma (MEL) who received adjuvant nivolumab (NIVO) without completion lymph node dissection (CLND) [abstract]. J Clin Oncol. 2019; 37 ( 15 suppl ): 9590.; Hieken TJ, Kane JM 3rd, Wong SL. The role of completion lymph node dissection for sentinel lymph node‐positive melanoma. Ann Surg Oncol. 2019; 26: 1028 ‐ 1034.; Wong SL, Faries MB, Kennedy EB, et al. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology clinical practice guideline update. J Clin Oncol. 2018; 36: 399 ‐ 413.; Moyers JT, Chong EG, Mitchell J, Patel A, Jeong ISD, Nagaraj G. Abstract 4338: Immunotherapy in resected stage III melanoma: an analysis of the National Cancer Database. Proceedings: AACR Annual Meeting 2020; June 22‐24, 2020; Philadelphia, PA. Cancer Res. 2020; 80 ( 16 suppl ): 4338.

الإتاحة: https://doi.org/10.1002/cncr.33483Test
https://hdl.handle.net/2027.42/168248Test

المؤلفون: Straker, Richard J, Carr, Michael J, Sinnamon, Andrew J, Shannon, Adrienne B, Sun, James, Landa, Karenia, Baecher, Kirsten M, Wood, Christian, Lynch, Kevin, Bartels, Harrison G, Panchaud, Robyn, Lowe, Michael C, Slingluff, Craig L, Jameson, Mark J, Tsai, Kenneth, Faries, Mark B, Beasley, Georgia M, Sondak, Vernon, Karakousis, Giorgos C, Zager, Jonathan S, Miura, John T

المصدر: USF-LVHN SELECT

مصطلحات موضوعية: Carcinoma, Merkel Cell, Female, Humans, Lymphatic Metastasis, Male, Neoplasm Recurrence, Local, Sentinel Lymph Node, Sentinel Lymph Node Biopsy, Skin Neoplasms, USF-LVHN SELECT Program, USF-LVHN SELECT Program Students, Medical Education, Medicine and Health Sciences

العلاقة: https://scholarlyworks.lvhn.org/select-program/464Test; https://pubmed.ncbi.nlm.nih.gov/33890195Test/

الإتاحة: https://scholarlyworks.lvhn.org/select-program/464Test
https://pubmed.ncbi.nlm.nih.gov/33890195Test/